StockData
DexCom Inc logo

DexCom Inc (DXCM) stock

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3031% below fair value
$82.04+0.43 (+0.53%)

Close on Nov 17, 2026Market cap $30.60BP/E 32.3Yield –

DexCom total assets

Total assets on the balance sheet at the end of each period.

DexCom's total assets was $6.24B at Sep 30, 2026. For fiscal 2025 it was $6.34B, down 2.2% from the year before. Over ten years it grew 36.0% a year on average. The highest annual figure on record is $6.48B in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.34B-2.2%
FY2024Dec 31, 2024$6.48B+3.5%
FY2023Dec 31, 2023$6.26B+16.2%
FY2022Dec 31, 2022$5.39B+9.3%
FY2021Dec 31, 2021$4.93B+15.0%
FY2020Dec 31, 2020$4.29B+79.1%
FY2019Dec 31, 2019$2.40B+25.0%
FY2018Dec 31, 2018$1.92B+111.9%
FY2017Dec 31, 2017$904.10M+124.5%
FY2016Dec 31, 2016$402.80M+37.9%
FY2015Dec 31, 2015$292.00M+58.2%
FY2014Dec 31, 2014$184.60M+50.7%
FY2013Dec 31, 2013$122.50M+15.6%
FY2012Dec 31, 2012$106.00M-12.0%
FY2011Dec 31, 2011$120.50M+56.2%
FY2010Dec 31, 2010$77.16M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$6.24B-16.8%
Q2 FY2026Jun 30, 2026$6.46B-11.9%
Q1 FY2026Mar 31, 2026$6.63B-1.8%
Q4 FY2025Dec 31, 2025$6.34B-2.2%
Q3 FY2025Sep 30, 2025$7.50B+18.0%
Q2 FY2025Jun 30, 2025$7.33B+7.8%
Q1 FY2025Mar 31, 2025$6.75B+4.2%
Q4 FY2024Dec 31, 2024$6.48B+3.5%
Q3 FY2024Sep 30, 2024$6.35B-3.7%
Q2 FY2024Jun 30, 2024$6.80B-0.3%
Q1 FY2024Mar 31, 2024$6.48B+17.5%
Q4 FY2023Dec 31, 2023$6.26B+16.2%
Q3 FY2023Sep 30, 2023$6.60B+34.6%
Q2 FY2023Jun 30, 2023$6.82B+30.7%
Q1 FY2023Mar 31, 2023$5.52B+9.1%
Q4 FY2022Dec 31, 2022$5.39B+9.3%
Q3 FY2022Sep 30, 2022$4.90B+2.6%
Q2 FY2022Jun 30, 2022$5.22B+15.8%
Q1 FY2022Mar 31, 2022$5.06B+15.2%
Q4 FY2021Dec 31, 2021$4.93B+15.0%
Q3 FY2021Sep 30, 2021$4.78B+24.6%
Q2 FY2021Jun 30, 2021$4.50B+27.9%
Q1 FY2021Mar 31, 2021$4.39B+79.3%
Q4 FY2020Dec 31, 2020$4.29B+79.1%
Q3 FY2020Sep 30, 2020$3.83B+75.4%
Q2 FY2020Jun 30, 2020$3.52B+70.5%
Q1 FY2020Mar 31, 2020$2.45B+24.0%
Q4 FY2019Dec 31, 2019$2.40B+25.0%
Q3 FY2019Sep 30, 2019$2.19B+96.2%
Q2 FY2019Jun 30, 2019$2.07B+105.1%
Q1 FY2019Mar 31, 2019$1.97B+120.1%
Q4 FY2018Dec 31, 2018$1.92B+111.9%
Q3 FY2018Sep 30, 2018$1.11B+32.2%
Q2 FY2018Jun 30, 2018$1.01B+26.6%
Q1 FY2018Mar 31, 2018$896.80M+92.0%
Q4 FY2017Dec 31, 2017$904.10M+124.5%
Q3 FY2017Sep 30, 2017$842.90M–
Q2 FY2017Jun 30, 2017$795.60M–
Q1 FY2017Mar 31, 2017$467.20M–
Q4 FY2016Dec 31, 2016$402.80M–

More DexCom figures

See a number that looks wrong?